Charlottesville’s Springbok Analytics Raises $5M with NBA Backing for Muscle Health AI
Technology developed at University of Virginia
Charlottesville, Va. – Springbok Analytics, a Charlottesville-based developer of artificial intelligence analytics focused on muscle health, has raised $5 million in its first round of funding, which included an investment from the National Basketball Association (NBA). The company’s technology provides athletes and trainers with data-driven insights to enhance performance and recovery. Chicago-based Transition Equity Partners led the round, which also included participation from Cartan Capital, Boston Global, an Australia-based firm, and others.
Springbok has developed an FDA-cleared AI technology that provides detailed muscle health assessments from MRI scans. The technology analyzes muscle and skeletal structures, providing detailed 3D visualizations and metrics, including muscle volume, composition and fat infiltration. The company’s technology is based on work from University of Virginia biomedical engineering professors. Springbok previously participated in the NBA’s Launchpad program, which supports emerging technologies that can support the NBA.
"The successful completion of our Series A funding is a significant milestone for Springbok Analytics, reflecting our team's singular focus on establishing the standard of care for muscle health and the growing recognition of our technology's potential," said co-founder and CEO Scott Magargee. "This investment will enable us to advance our mission to improve muscle health analysis and expand our impact across clinical care, research and health.”